IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 1962;1:178-186.)
© 1962 by The Association for Research in Vision and Ophthalmology, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KINOSHITA, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KINOSHITA, J. H.

Some Aspects of the Carbohydrate Metabolism of the Cornea

JIN H. KINOSHITA 1

1 Howe Laboratory of Ophthalmology, Harvard Medical School, and the Massachusetts Eye and Ear Infirmary Boston, Mass.

A review of certain features of the carbohydrate metabolism of cornea is presented. The possible mechanisms oxidizing the reduced form of triphosphopyridine nucleotide (TPNH) generated in the hexose monophosphate shunt pathway are considered. One such mechanism is the oxidation of TPNH through the lactic dehydrogenase reaction. Evidence indicates that glucose oxidation through the shunt mechanism is inhibited by low levels of iodoacetate. Since oxidation through the citric acid cycle is not inhibited, the mechanism reoxidizing TPNH formed in the shunt mechanism appears to be different from that involved with the citric acid cycle. Moreover, the addition of pyruvate overcomes the iodoacetate inhibition of the shunt mechanism. These findings support the contention that oxidation of TPNH may proceed through the lactic dehydrogenase reaction. Certain requirements must be met before this mechanism can function under normal physiologic conditions: (1) diphosphopyridine nucleotide (DPN) must be in the oxidized form, or at least, DPNH must be of sufficiently low concentration so that it would not compete with TPNH for pyruvate; (2) a pH lower than 7.4 greatly enhances this mechanism; and (3) sufficient amounts of pyruvate must be present.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1962 by the Association for Research in Vision and Ophthalmology